Arkolith/Insider Trading/THRX/Form 4

Dukes Iain D.

DirectorTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Feb 14, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2024Tender(U)388K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2024Disposed to issuer(D)36K——0
Feb 14, 2024Disposed to issuer(D)62K——0
Feb 14, 2024Disposed to issuer(D)344K——0
Feb 14, 2024Disposed to issuer(D)3K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-023556) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML